The Brien Holden Vision Institute (BHVI) has signed a licensing agreement that will see its algorithms for tracking and estimating refractive error incorporated into a world-first instrument for myopia management. Read more
ASX-listed Visioneering Technologies (VTI) has signed a sales and distribution deal with Japan’s largest contact lens company, mapping a path into the lucrative European market. Read more
New cases of incorrectly dispensed atropine formulations have prompted calls for eyecare professionals to make annotations to scripts in order to prevent further misunderstandings among pharmacists. Read more
ASX-listed medical device company Visioneering Technologies (VTI) is aiming to raise up to $11.1 million in new capital after securing fresh commitments from lead investors.